Proliferative capacity of corneal endothelial cells

被引:244
作者
Joyce, Nancy C. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA
关键词
corneal endothelium; proliferation; cell cycle; age; oxidative stress; DNA damage; GROWTH-FACTOR-BETA; PROTEIN-TYROSINE PHOSPHATASE-1B; LARGE T-ANTIGEN; S-PHASE ENTRY; OLDER DONORS; DNA-DAMAGE; MESSENGER-RNA; RECEPTOR EXPRESSION; CELLULAR SENESCENCE; MITOTIC INHIBITION;
D O I
10.1016/j.exer.2011.08.014
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The corneal endothelial monolayer helps maintain corneal transparency through its barrier and ionic "pump" functions. This transparency function can become compromised, resulting in a critical loss in endothelial cell density (ECD), corneal edema, bullous keratopathy, and loss of visual acuity. Although penetrating keratoplasty and various forms of endothelial keratoplasty are capable of restoring corneal clarity, they can also have complications requiring re-grafting or other treatments. With the increasing worldwide shortage of donor corneas to be used for keratoplasty, there is a greater need to find new therapies to restore corneal clarity that is lost due to endothelial dysfunction. As a result, researchers have been exploring alternative approaches that could result in the in vivo induction of transient corneal endothelial cell division or the in vitro expansion of healthy endothelial cells for corneal bioengineering as treatments to increase ECD and restore visual acuity. This review presents current information regarding the ability of human corneal endothelial cells (HCEC) to divide as a basis for the development of new therapies. Information will be presented on the positive and negative regulation of the cell cycle as background for the studies to be discussed. Results of studies exploring the proliferative capacity of HCEC will be presented and specific conditions that affect the ability of HCEC to divide will be discussed. Methods that have been tested to induce transient proliferation of HCEC will also be presented. This review will discuss the effect of donor age and endothelial topography on relative proliferative capacity of HCEC, as well as explore the role of nuclear oxidative DNA damage in decreasing the relative proliferative capacity of HCEC. Finally, potential new research directions will be discussed that could take advantage of and/or improve the proliferative capacity of these physiologically important cells in order to develop new treatments to restore corneal clarity. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:16 / 23
页数:8
相关论文
共 99 条
[1]   Morphological and functional analysis of immortalized human corneal endothelial cells after transplantation [J].
Aboalchamat, B ;
Engelmann, K ;
Böhnke, M ;
Eggli, P ;
Bednarz, J .
EXPERIMENTAL EYE RESEARCH, 1999, 69 (05) :547-553
[2]   Human hepatocyte growth factor (HGF) in the aqueous humor [J].
Araki-Sasaki, K ;
Danjo, S ;
Kawaguchi, S ;
Hosohata, J ;
Tano, Y .
JAPANESE JOURNAL OF OPHTHALMOLOGY, 1997, 41 (06) :409-413
[3]   DISTRIBUTION OF IGF-I AND IGF-II, IGF BINDING-PROTEINS (IGFBPS) AND IGFBP MESSENGER-RNA IN OCULAR FLUIDS AND TISSUES - POTENTIAL SITES OF SYNTHESIS OF IGFBPS IN AQUEOUS AND VITREOUS [J].
ARNOLD, DR ;
MOSHAYEDI, P ;
SCHOEN, TJ ;
JONES, BE ;
CHADER, GJ ;
WALDBILLIG, RJ .
EXPERIMENTAL EYE RESEARCH, 1993, 56 (05) :555-565
[4]  
BAUM JL, 1979, ARCH OPHTHALMOL-CHIC, V97, P1136
[5]   Oxidative decay of DNA [J].
Beckman, KB ;
Ames, BN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) :19633-19636
[6]  
Bednarz J, 1998, IN VITRO CELL DEV-AN, V34, P149
[7]   The signals and pathways activating cellular senescence [J].
Ben-Porath, I ;
Weinberg, RA .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (05) :961-976
[8]  
Blake DA, 1997, INVEST OPHTH VIS SCI, V38, P1119
[9]  
Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779
[10]  
BURKE JM, 1988, INVEST OPHTH VIS SCI, V29, P1784